With the growth of Asian economies spurring on the expansion of Asian medical markets, medical and pharmaceutical companies in the West are increasingly looking to Asia for outsourcing. Western medical device and pharmaceutical companies have begun to outsource research and development, clinical... Read More
In response to concerns about the safety and effectiveness of pharmaceutical manufacturing in China, the State Food and Drug Administration (SFDA) will require Good Manufacturing Practice (GMP) authentication for all Chinese pharmaceutical manufacturers. The regulation goes into effect on July 1, 2004,... Read More
The Malaysian National Pharmaceutical Control Bureau (NPCB) regulates the registration and authorization of manufacturing site changes for pharmaceutical production. There are five types of manufacturing site changes. Type I: Change of manufacturing site within Malaysia As a result of upgrading of facilities... Read More
On August 29, 2003, a drugs pact backed by the United States was rejected by the World Trade Organization (WTO). The pact was meant to set limitations on the Doha declaration allowing poorer countries access to cheaper, generic medicines, including those covered... Read More
In a move to raise competitiveness in the pharmaceutical industry in China, the State Food and Drug Administration (SFDA), the government body which has replaced the State Drug Administration for some pharmaceutical regulatory functions in China, has lifted price controls on over... Read More
In an effort to prevent and reduce errors in administering medication, Taiwan’s Legislative Yuan (Council) ratified a revision of the Pharmacy Law on January, 14, 2003, requiring that all medicines sold in Taiwan must have labels in Chinese. Due to increased instances... Read More
Despite the slowing economies, Asia still continues to offer medical device manufacturers many investment opportunities. With information and updates on China, Malaysia, Thailand, the Philippines and ASEAN, this article highlights the benefits and advantages of manufacturing medical devices in Asia. Asian countries... Read More
Indian drug manufacturers and the International Federation of Pharmaceutical Manufacturers Association (IFPMA), which represents multinational, research-driven, pharmaceutical companies around the world, recently clashed over the production of counterfeit drugs in India. In late January 2003, IFPMA accused the Indian pharmaceutical industry of... Read More
The Singaporean government has been stepping up its efforts to build the country into a biotechnology hub. With more than S$3 billion (US$ 1.7 billion) set aside for development of biomedical sciences in Singapore over the next five years, Singapore’s Economic Development... Read More
More and more medical device companies are making their products in Asia via contract manufacturing, joint ventures or setting up their own shop. Contract manufacturing is an efficient means by which medical manufacturers can utilize production facilities already available in Asian countries.... Read More